Bundamedik Tbk vs Sinergi Multi Lestarindo Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Sinergi Multi Lestarindo Tbk. trades at Rp128 (market cap 302.66B, 13.94M 24h volume). The key difference: Bundamedik Tbk is far larger — about 5× Sinergi Multi Lestarindo Tbk.'s market cap, and Sinergi Multi Lestarindo Tbk. is more actively traded (13.94M versus 536.7K). Which is the better fit depends on your goals.
| BMHS | SMLE | |
|---|---|---|
Market Cap | 1.51T | 302.66B |
Volume | 536.7K | 13.94M |
Lot | 5.37K | 139.35K |
Turnover | 93.41M | 1.79B |
Average Price | 174.05 | 128.36 |
Value | 93.41M | 1.79B |
Indicative Equilibrium Price | 176 | 128 |
Indicative Equilibrium Volume | 100 | 17 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.
Read more on SMLE →